Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 413,066. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tulsa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tulsa storefront.
Biologic Solutions for Chronic Wounds in Tulsa, OK for clinics & physicians. Biologic solutions for chroni… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into an Oklahoma chart is a denial pattern. You are JH. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Use Oklahoma State Department of Health for community education; use the IFU for the product in the fridge. biologic solutions chronic wounds is the SKU conversation, not a patient appointment book.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)Oklahoma shares JH with AR, CO, LA, MS, NM, TX. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Tulsa trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tulsa trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
Oklahoma is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
Bring specialty, monthly wound volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.8% diabetes and 25.1% arthritis for Tulsa — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Tulsa, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tulsa is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tulsa — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tulsa. Useful for joint-program math; still needs a diagnosis and privileging.
No Tulsa storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.